Viewing Study NCT05909904


Ignite Creation Date: 2025-12-24 @ 9:15 PM
Ignite Modification Date: 2025-12-25 @ 7:04 PM
Study NCT ID: NCT05909904
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-07
First Post: 2023-06-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma
Sponsor: BeiGene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module